Affiliation:
1. Department of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai P.O. Box 505055, United Arab Emirates
2. Sharjah Institute for Medical Research, College of Medicine, University of Sharjah, Sharjah P.O. Box 27272, United Arab Emirates
Abstract
Breast cancer (BC) is one of the most common types of cancer in women in the United Arab Emirates. Immunogenic tumours, such as triple-negative breast cancer (TNBC), show increased neutrophil infiltration, which is associated with poor prognosis and limited efficacy of immunotherapy. This study aims to investigate in vitro the bidirectional effect of neutrophils on metastatic TNBC (MDA-MB-231) compared to less-metastatic luminal breast cancer (MCF-7) cell lines. We found that BC cells or their conditioned medium (CM) reduced the viability of neutrophil-like cells (HL60). This was supported by increased cellular stress and NETosis in differentiated HL60 cells (dHL60) upon exposure to MDA-MB-231 compared to MCF-7-CM using nucleic acid staining essays. Flow cytometry showed comparable expression of inflammatory markers by polymorphonuclear cells (PMN) when treated with MDA-MB-231-CM and standard polarizing cocktails. Furthermore, MDA-MB-231-CM triggered an inflammatory pattern with evidence of stronger adhesion (CD62L) and degranulation (CD11b and CD66b) phenotypes. The proinflammatory polarization of dHL60 by MDA-MB-231-CM was additionally confirmed by the elevated CD54 expression, myeloperoxidase, and CD11b protein levels, which matched an increased transwell migratory capacity. In conclusion, BC might use neutrophils to their benefit through NETosis and complement system activation, which makes this crosstalk a potential mechanism for understanding tumour progression.
Funder
Mohammad Bin Rashid University of Medicine and Health Sciences
Reference61 articles.
1. Breast Cancer in the United Arab Emirates;Abdelwahed;JCO Glob. Oncol.,2023
2. Elobaid, Y., Aamir, M., Grivna, M., Suliman, A., Attoub, S., Mousa, H., Ahmed, L.A., and Oulhaj, A. (2021). Breast cancer survival and its prognostic factors in the United Arab Emirates: A retrospective study. PLoS ONE, 16.
3. Ribeiro, R., Carvalho, M.J., Goncalves, J., and Moreira, J.N. (2022). Immunotherapy in triple-negative breast cancer: Insights into tumor immune landscape and therapeutic opportunities. Front. Mol. Biosci., 9.
4. Immunotherapy in breast cancer: An overview of current strategies and perspectives;Debien;NPJ Breast Cancer,2023
5. Neutrophils: A roadblock for immunotherapy;Mir;Nat. Rev. Cancer,2022